Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cencora, Inc. stock logo
COR
Cencora
$296.23
+1.7%
$291.12
$218.65
$309.35
$57.42B0.571.51 million shs614,990 shs
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%
C$0.26
C$0.15
C$0.53
C$52.28MN/A644,760 shs384,329 shs
Evercore Inc stock logo
EVR
Evercore
$287.29
+1.6%
$239.37
$148.63
$324.06
$11.25B1.43494,065 shs321,982 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cencora, Inc. stock logo
COR
Cencora
0.00%-1.16%+2.89%+6.07%+33.14%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%
Evercore Inc stock logo
EVR
Evercore
0.00%+6.44%+20.45%+75.52%+36.16%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cencora, Inc. stock logo
COR
Cencora
4.6716 of 5 stars
2.43.03.33.13.53.31.3
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Evercore Inc stock logo
EVR
Evercore
4.5283 of 5 stars
2.43.04.21.83.31.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cencora, Inc. stock logo
COR
Cencora
2.82
Moderate Buy$306.333.41% Upside
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00
N/AN/AN/A
Evercore Inc stock logo
EVR
Evercore
2.71
Moderate Buy$250.57-12.78% Downside

Current Analyst Ratings Breakdown

Latest EVR, COR, G1A, and EMH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Cencora, Inc. stock logo
COR
Cencora
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$275.00 ➝ $300.00
6/23/2025
Evercore Inc stock logo
EVR
Evercore
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$175.00 ➝ $312.00
6/3/2025
Cencora, Inc. stock logo
COR
Cencora
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$274.00 ➝ $337.00
5/15/2025
Evercore Inc stock logo
EVR
Evercore
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$234.00 ➝ $266.00
5/12/2025
Evercore Inc stock logo
EVR
Evercore
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$238.00 ➝ $257.00
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$330.00 ➝ $355.00
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$314.00 ➝ $350.00
5/1/2025
Evercore Inc stock logo
EVR
Evercore
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$173.00 ➝ $175.00
5/1/2025
Evercore Inc stock logo
EVR
Evercore
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$180.00 ➝ $194.00
4/29/2025
Cencora, Inc. stock logo
COR
Cencora
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$298.00 ➝ $335.00
4/15/2025
Cencora, Inc. stock logo
COR
Cencora
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$288.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cencora, Inc. stock logo
COR
Cencora
$293.96B0.20$19.88 per share14.90$4.04 per share73.32
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64
Evercore Inc stock logo
EVR
Evercore
$3.09B3.63$10.89 per share26.38$50.94 per share5.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cencora, Inc. stock logo
COR
Cencora
$1.51B$8.6234.3717.551.470.55%344.71%4.26%8/6/2025 (Confirmed)
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/AN/AN/AN/AN/AN/A
Evercore Inc stock logo
EVR
Evercore
$378.28M$10.4527.4912.85N/A14.13%26.53%13.34%7/23/2025 (Estimated)

Latest EVR, COR, G1A, and EMH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q3 2025
Cencora, Inc. stock logo
COR
Cencora
$3.79N/AN/AN/A$80.34 billionN/A
7/23/2025Q2 2025
Evercore Inc stock logo
EVR
Evercore
$1.40N/AN/AN/A$657.17 millionN/A
5/7/2025Q2 2025
Cencora, Inc. stock logo
COR
Cencora
$4.07$4.42+$0.35$3.68$75.41 billion$75.50 billion
4/30/2025Q1 2025
Evercore Inc stock logo
EVR
Evercore
$1.60$3.49+$1.89$3.48$704.54 million$699.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cencora, Inc. stock logo
COR
Cencora
$2.200.74%N/A25.52%15 Years
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A
Evercore Inc stock logo
EVR
Evercore
$3.361.17%N/A32.15%18 Years

Latest EVR, COR, G1A, and EMH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2025
Evercore Inc stock logo
EVR
Evercore
quarterly$0.841.69%5/30/20255/30/20256/13/2025
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.8%5/16/20255/16/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cencora, Inc. stock logo
COR
Cencora
6.01
0.87
0.52
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61
Evercore Inc stock logo
EVR
Evercore
0.17
3.25
1.96

Institutional Ownership

CompanyInstitutional Ownership
Cencora, Inc. stock logo
COR
Cencora
97.52%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A
Evercore Inc stock logo
EVR
Evercore
86.23%

Insider Ownership

CompanyInsider Ownership
Cencora, Inc. stock logo
COR
Cencora
10.80%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A
Evercore Inc stock logo
EVR
Evercore
6.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000193.82 million172.89 millionOptionable
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable
Evercore Inc stock logo
EVR
Evercore
2,38039.12 million36.74 millionOptionable

Recent News About These Companies

YieldBoost Evercore To 12.9% Using Options - Nasdaq
Best Momentum Stock to Buy for June 25th
Evercore Inc: Chart Analysis
Best Income Stocks to Buy for June 25th
New Strong Buy Stocks for June 25th
Morgan Stanley Upgrades Evercore (EVR)
5EVR : Where Evercore Stands With Analysts
New Strong Buy Stocks for June 11th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cencora stock logo

Cencora NYSE:COR

$296.23 +5.06 (+1.74%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$295.00 -1.23 (-0.42%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Emerald Health Therapeutics stock logo

Emerald Health Therapeutics CVE:EMH

C$0.26 -0.01 (-3.77%)
As of 04/26/2021

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Evercore stock logo

Evercore NYSE:EVR

$287.29 +4.55 (+1.61%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$287.29 +0.00 (+0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evercore Inc., together with its subsidiaries, operates as an independent investment banking advisory firm in the United States, Europe, Latin America, and internationally. It operates through two segments, Investment Banking & Equities, and Investment Management. The Investment Banking & Equities segment offers strategic advisory services, such as mergers, and acquisitions, strategic, defense, and shareholder advisory, special committee assignments, and real estate strategic advisory; private capital advisory and fundraising, market risk management and hedging, private capital markets and debt advisory, liability management and restructuring, and equity capital markets execution and advisory services; and research, sales, and trading professionals services on a content-led platform to its institutional investor clients. The Investment Management segment provides wealth management services to high-net-worth individuals, foundations, and endowments; and manages financial assets for institutional investors. The company was formerly known as Evercore Partners Inc. and changed its name to Evercore Inc. in August 2017. Evercore Inc. was founded in 1995 and is headquartered in New York, New York.